The hepatitis C market is projected to reach $153.67 billion by 2030, growing at 15.4% CAGR, driven by direct-acting antivirals, early screening, and expanded access to treatment.
Read MoreGlobal Hepatic Encephalopathy market size is expected to reach $2.38 billion by 2030 at 6%, segmented as by antibiotics, rifaximin, neomycin, metronidazole
Read MoreGlobal Hemorrhoids market size is expected to reach $3.96 Billion by 2030 at 6.2%, rising demand for over-the-counter (otc) products driving the growth of the market due to increasing consumer preference for self-care and convenience
Read MoreGlobal Hemorrhage Control System market size is expected to reach $4.67 billion by 2030 at 6.1%, rising prevalence of trauma cases driving the market growth
Read MoreGlobal Hemophilia market size is expected to reach $23.17 billion by 2030 at 9.3%, segmented as by hemophilia a, severe hemophilia a, moderate hemophilia a, mild hemophilia a
Read MoreGlobal Hemophagocytic Lymphohistiocytosis market size is expected to reach $3.24 billion by 2030 at 5.8%, impact of rising prevalence of autoimmune diseases on the market
Read MoreGlobal Hemoglobinopathies Treatment market size is expected to reach $14.79 billion by 2030 at 8.2%, segmented as by stem cell therapy, hematopoietic stem cell transplantation (hsct), gene therapy for hemoglobinopathies, autologous stem cell therapy
Read MoreGlobal Hemoglobin A1c (HbA1c) Testing market size is expected to reach $3.31 billion by 2030 at 10.3%, segmented as by laboratory-based testing, high-performance liquid chromatography (hplc) testing, ion-exchange chromatography
Read MoreGlobal Hemodynamic Monitoring Systems market size is expected to reach $2.42 billion by 2030 at 7.8%, segmented as by monitors, bedside monitors, handheld monitors, portable monitors
Read MoreGlobal Hemodialysis Catheter market size is expected to reach $1.59 billion by 2030 at 7.1%, rising prevalence of chronic kidney disease driving demand for hemodialysis solutions
Read More
